» Articles » PMID: 23231663

Intraoperative Electron Radiation Therapy (IOERT) in the Management of Locally Recurrent Rectal Cancer

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2012 Dec 13
PMID 23231663
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To evaluate disease control, overall survival and prognostic factors in patients with locally recurrent rectal cancer after IOERT-containing multimodal therapy.

Methods: Between 1991 and 2006, 97 patients with locally recurrent rectal cancer have been treated with surgery and IOERT. IOERT was preceded or followed by external beam radiation therapy (EBRT) in 54 previously untreated patients (median dose 41.4 Gy) usually combined with 5-Fluouracil-based chemotherapy (89%). IOERT was delivered via cylindric cones with doses of 10-20 Gy. Adjuvant CHT was given only in a minority of patients (34%). Median follow-up was 51 months.

Results: Margin status was R0 in 37%, R1 in 33% and R2 in 30% of the patients. Neoadjuvant EBRT resulted in significantly increased rates of free margins (52% vs. 24%). Median overall survival was 39 months. Estimated 5-year rates for central control (inside the IOERT area), local control (inside the pelvis), distant control and overall survival were 54%, 41%, 40% and 30%. Resection margin was the strongest prognostic factor for overall survival (3-year OS of 80% (R0), 37% (R1), 35% (R2)) and LC (3-year LC 82% (R0), 41% (R1), 18% (R2)) in the multivariate model. OS was further significantly affected by clinical stage at first diagnosis and achievement of local control after treatment in the univariate model. Distant failures were found in 46 patients, predominantly in the lung. 90-day postoperative mortality was 3.1%.

Conclusion: Long term OS and LC can be achieved in a substantial proportion of patients with recurrent rectal cancer using a multimodality IOERT-containing approach, especially in case of clear margins. LC and OS remain limited in patients with incomplete resection. Preoperative re-irradiation and adjuvant chemotherapy may be considered to improve outcome.

Citing Articles

Outcome of intraoperative brachytherapy as a salvage treatment for locally recurrent rectal cancer.

Stoian R, Neeff H, Gainey M, Kollefrath M, Kirste S, Zamboglou C Strahlenther Onkol. 2024; 201(1):27-35.

PMID: 39115680 PMC: 11739204. DOI: 10.1007/s00066-024-02271-1.


Novel and Innovative Surgical Strategies for Recurrent Rectal Cancer: Uncommon Resections, Local Interventions for Pelvic Reoccurrence, and Intraoperative Radiation Therapy.

Webb S, Ahmad I Clin Colon Rectal Surg. 2024; 37(2):66-70.

PMID: 38322600 PMC: 10843878. DOI: 10.1055/s-0043-1761473.


First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer: technical procedure.

Roeder F, Fastner G, Fussl C, Sedlmayer F, Stana M, Berchtold J Radiat Oncol. 2023; 18(1):186.

PMID: 37950314 PMC: 10638784. DOI: 10.1186/s13014-023-02374-6.


Different RONS Generation in MTC-SK and NSCL Cells Lead to Varying Antitumoral Effects of Alpha-Ketoglutarate + 5-HMF.

Greilberger J, Erlbacher K, Stiegler P, Wintersteiger R, Herwig R Curr Issues Mol Biol. 2023; 45(8):6503-6525.

PMID: 37623229 PMC: 10453038. DOI: 10.3390/cimb45080410.


Comparing Oncologic Outcomes and Toxicity for Combined Modality Therapy vs. Carbon-Ion Radiotherapy for Previously Irradiated Locally Recurrent Rectal Cancer.

Jeans E, Ebner D, Takiyama H, Qualls K, Cunningham D, Waddle M Cancers (Basel). 2023; 15(11).

PMID: 37297019 PMC: 10253149. DOI: 10.3390/cancers15113057.


References
1.
Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R . Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351(17):1731-40. DOI: 10.1056/NEJMoa040694. View

2.
Valentini V, Morganti A, Gambacorta M, Mohiuddin M, Doglietto G, Coco C . Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys. 2006; 64(4):1129-39. DOI: 10.1016/j.ijrobp.2005.09.017. View

3.
Nielsen M, Laurberg S, Holm T . Current management of locally recurrent rectal cancer. Colorectal Dis. 2010; 13(7):732-42. DOI: 10.1111/j.1463-1318.2009.02167.x. View

4.
Palmer G, Martling A, Cedermark B, Holm T . A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2006; 14(2):447-54. DOI: 10.1245/s10434-006-9256-9. View

5.
Mohiuddin M, Marks G, Marks J . Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer. 2002; 95(5):1144-50. DOI: 10.1002/cncr.10799. View